IRB Barcelona - Institute for Research in Biomedicine -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia

    European Neuropsychopharmacology, Vol. 27, Núm. 2, pp. 180-191